This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Showing all 30 results
Variants in the Sequence of the Probe Hybridization Site May Affect MLPA Performance in Patients with Duchenne/Becker Muscular Dystrophy
#apaperaday: Sharing "Negative" Results in Neuromuscular Research: A Positive Experience
Sharing "Negative" Results in Neuromuscular Research: A Positive Experience
#apaperaday: Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies
Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies
#apaperaday: Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy
Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy
#apaperaday: 263rd ENMC International Workshop: Focus on female carriers of dystrophinopathy
263rd ENMC International Workshop: Focus on female carriers of dystrophinopathy: refining recommendations for prevention, diagnosis, surveillance, and treatment.
#apaperaday: A manifesting female carrier of Duchenne muscular dystrophy: Importance of genetics for the dystrophinopathies
A manifesting female carrier of Duchenne muscular dystrophy: Importance of genetics for the dystrophinopathies
#apaperaday: Accuracy of Non-Invasive Prenatal Testing for Duchenne Muscular Dystrophy in Families at Risk: A Systematic Review
Accuracy of Non-Invasive Prenatal Testing for Duchenne Muscular Dystrophy in Families at Risk: A Systematic Review
#apaperaday: Time to diagnosis of Duchenne muscular dystrophy in Austria and Germany
Time to diagnosis of Duchenne muscular dystrophy in Austria and Germany
#apaperaday: Spectrum of Genetic Variants in the Dystrophin Gene: A Single Centre Retrospective Analysis of 750 Duchenne and Becker Patients from Southern Italy
Spectrum of Genetic Variants in the Dystrophin Gene: A Single Centre Retrospective Analysis of 750 Duchenne and Becker Patients from Southern Italy
#apaperaday: Mechanisms of Myofibre Death in Muscular Dystrophies: The Emergence of the Regulated Forms of Necrosis in Myology
Mechanisms of Myofibre Death in Muscular Dystrophies: The Emergence of the Regulated Forms of Necrosis in Myology
#apaperaday: Duchenne Muscular Dystrophy in Kazakhstan: A Journey from Diagnosis to the Treatment, the Biases and Achievements
Duchenne Muscular Dystrophy in Kazakhstan: A Journey from Diagnosis to the Treatment, the Biases and Achievements
#apaperaday: A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable?
A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable?
#apaperaday: What Can RNA-Based Therapy Do for Monogenic Diseases?
What Can RNA-Based Therapy Do for Monogenic Diseases?
#apaperaday: Identification of Biallelic dystrophin gene variants during maternal carrier testing for Becker muscular dystrophy and review of the DMD exon 49–51 deletion phenotype
Identification of Biallelic dystrophin gene variants during maternal carrier testing for Becker muscular dystrophy and review of the DMD exon 49–51 deletion phenotype
#apaperaday: Very Low Residual Dystrophin Quantity Is Associated with Milder Dystrophinopathy
Very Low Residual Dystrophin Quantity Is Associated with Milder Dystrophinopathy
#apaperaday: The discovery of the DNA methylation episignature for Duchenne muscular dystrophy
The discovery of the DNA methylation episignature for Duchenne muscular dystrophy
#apaperaday: Racial and ethnic differences in timing of diagnosis and clinical services received in Duchenne Muscular Dystrophy
Racial and ethnic differences in timing of diagnosis and clinical services received in Duchenne Muscular Dystrophy
#apaperaday: Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle
Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle
#apaperaday: Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy
Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy
#apaperaday: Biological and genetic therapies for the treatment of Duchenne muscular dystrophy
Biological and genetic therapies for the treatment of Duchenne muscular dystrophy
#apaperaday: Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy
#apaperaday: Genetic diagnosis of Duchenne and Becker muscular dystrophy through mRNA analysis: new splicing events
Genetic diagnosis of Duchenne and Becker muscular dystrophy through mRNA analysis: new splicing events
#apaperaday: Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy
Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy
#apaperaday: Clinical potential of microdystrophin as a surrogate endpoint
Clinical potential of microdystrophin as a surrogate endpoint
#apaperaday: Brother of Cure Rare Disease CEO Dies in Trial of Duchenne Muscular Dystrophy Therapy
Brother of Cure Rare Disease CEO Dies in Trial of Duchenne Muscular Dystrophy Therapy
#apaperaday: Trabecular Bone Volume Is Reduced, With Deteriorated Microstructure, With Aging in a Rat Model of Duchenne Muscular Dystrophy
Trabecular Bone Volume Is Reduced, With Deteriorated Microstructure, With Aging in a Rat Model of Duchenne Muscular Dystrophy
#apaperaday: Bridging the Gap With Clinical Pharmacology in Innovative Rare Disease Treatment Modalities: Targeting DNA to RNA to Protein
Bridging the Gap With Clinical Pharmacology in Innovative Rare Disease Treatment Modalities: Targeting DNA to RNA to Protein
#apaperaday: Electrical Impedance Myography Correlates with Functional Measures of Disease Progression in D2-mdx Mice and Boys with Duchenne Muscular Dystrophy
Electrical Impedance Myography Correlates with Functional Measures of Disease Progression in D2-mdx Mice and Boys with Duchenne Muscular Dystrophy
#apaperaday: Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-β via Smad3 acetylation
Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-β via Smad3 acetylation
#apaperaday: Cardiac and Skeletal Muscle Pathology in the D2/mdx Mouse Model and Caveats Associated with the Quantification of Utrophin.
Cardiac and Skeletal Muscle Pathology in the D2/mdx Mouse Model and Caveats Associated with the Quantification of Utrophin.